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Summary
Familial calcium pyrophosphate dihydrate deposition
disease (CPPDD) is a disease of articular cartilage that
is radiographically characterized by chondrocalcinosis
due to the deposition of calcium-containing crystals in
affected joints. We have documented the disease in an
Argentinean kindred of northern Italian ancestry and in
a French kindred from the Alsace region. Both families
presented with a common phenotype including early age
at onset and deposition of crystals of calcium pyro-
phosphate dihydrate in a similar pattern of affected
joints. Affected family members were karyotypically
normal. Linkage to the short arm of chromosome 5 was
observed, consistent with a previous report of linkage
of the CPPDD phenotype in a large British kindred to
the 5p15 region. However, recombinants in the Argen-
tinean kindred have enabled us to designate a region
!1 cM in length between the markers D5S416 and
D5S2114 as the CPPDD locus.
Introduction
Zitnan and Sitaj (1958, 1963) presented case studies of
27 patients with what they referred to as “articular chon-
drocalcinosis.” The fact that most of the patients were
members of five families suggested that the disease has
a strong hereditary component. McCarty and Hollander
(1961) reported on two cases of non–urate-associated
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crystal deposition in the joints of patients thought to
have gout. Radiographic examination of the joints in
these and other patients revealed distinctive and abnor-
mal calcifications in and around articular hyaline car-
tilage and fibrocartilage of numerous joints. Following
the initial description of calcium pyrophosphate dihy-
drate deposition disease (CPPDD) in the five Czech fam-
ilies, multiple ethnic series were reported from through-
out the world (Louyot et al. 1964; Moskowitz and Katz
1964; van der Korst et al. 1974; Reginato et al. 1975;
Gaucher et al. 1977; Gaudreau et al. 1981; Bjelle 1982;
Sakaguchi et al. 1982; Richardson et al. 1983; Ferna´n-
dez-Dapica and Go´mez-Reino 1986; Rodrı´guez-Val-
verde et al. 1988; Balsa et al. 1990; Eshel et al. 1990;
Doherty et al. 1991; Hamza et al. 1992). Most familial
cases appeared to be inherited in an autosomal dominant
manner, with precocious onset and variable clinical ex-
pression; deposition of calcium pyrophosphate dihy-
drate (CPPD) crystals frequently preceded the develop-
ment of arthropathy. The radiographic features included
crystal deposition in the knee, symphysis pubis, and tri-
angular fibrocartilage of the wrist (Riestra et al. 1988;
Ryan and McCarty 1993). A peculiar type of osteoar-
thritis with numerous and large subchondral cysts was
also observed.
In primary familial cases of chondrocalcinosis, crystal
deposition prior to the onset of degenerative joint disease
is observed. The disorder may also be sporadic or as-
sociated with several metabolic disorders, such as hy-
pophosphatasia, hypomagnesemia, hemochromatosis,
and hyperparathyroidism. The mechanisms responsible
for the deposition of the CPPD crystals are not known,
although some studies have reported that structural
changes in the articular cartilage extracellular matrix
might promote crystal formation (Bjelle 1972, 1981). In
light of these reports, genes encoding cartilage extracel-
lular-matrix proteins have been considered as candidate
genes for chondrocalcinosis. In a large family from the
Chiloe Islands, with a clinical phenotype of severe, pre-
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cocious osteoarthritis with ankylosis, late-onset spon-
dyloepiphyseal dysplasia, and chondrocalcinosis in mul-
tiple joints and fibrocartilages, a heterozygous mutation
in the COL2A1 gene that resulted in an R75C substi-
tution in the gene product was identified (Williams et
al. 1993; Reginato et al. 1994). However, it appears that
in this family the chondrocalcinosis phenotype was a
secondary consequence of the advanced and severe os-
teoarthritis. It has also been suggested that the inorganic
composition of the matrix may affect crystal deposition.
A chondrocyte nucleoside triphosphate pyrophospho-
hydrolase (NTPPPH) that may play a role in the extra-
cellular generation of inorganic pyrophosphate at the
site of crystal deposition has been characterized (Howell
et al. 1984; Muniz et al. 1984; Ryan et al. 1984, 1985).
The activity of this enzyme was elevated in sporadic
cases of CPPDD; however, elevated levels of NTPPPH
activity were not observed in the familial form of the
disease (Ryan et al. 1986). Nonetheless, increased levels
of inorganic pyrophosphate have been observed in cul-
tured fibroblasts and lymphoblasts of patients affected
with familial CPPDD (Lust et al. 1981a, 1981b), which
thus perpetuates the suspicion that abnormalities in py-
rophosphate metabolism may give rise to abnormal crys-
tal deposition in these families.
In recent years, genetic linkage analysis has been un-
dertaken to map the disease gene(s) for familial CPPDD.
A study of a large family from Maine, in which the
CPPDD phenotype appeared to occur as a secondary
consequence of severe, nondysplastic osteoarthritis, ex-
cluded linkage to the COL2A1 locus; in this family, ge-
netic linkage was demonstrated between the disease phe-
notype and a locus on the long arm of chromosome 8
(MIM 600668; Baldwin et al. 1995). A study of a British
family with a phenotype of primary chondrocalcinosis
and childhood seizures demonstrated genetic linkage to
a chromosomal interval in the region of 5p15 (MIM
118600; gene symbol CCAL1; Hughes et al. 1995). In
this report we document linkage of the primary CPPDD
phenotype to the short arm of chromosome 5 in two
unrelated families, one from Argentina and the other
from France. Recombination events in the Argentinean
kindred assign the CPPDD locus to a 1-cM region just
centromeric to the locus reported for the British kindred.
The results of all these studies indicate that familial
CPPDD is a clinically and genetically heterogeneous dis-
ease and that mutations in at least three different genes
may eventually lead to the expression of the disease.
Subjects, Material, and Methods
Family Studies and Collection of Material
The subjects of this study were from two families: an
Argentinean kindred of northern Italian (Cuneo, Pia-
monte) ancestry and a French kindred from the Alsace
region. Among the Argentinean kindred, 77 members
from four generations, with 27 affected individuals, were
analyzed in the study. In the French kindred, 41 members
from three generations, with 25 affected individuals,
provided DNA for genotype analyses. The CPPDD phe-
notype in both families displayed an autosomal domi-
nant mode of inheritance. Affected members were ini-
tially evaluated by clinical examination. Follow-up
evaluations with detailed radiographs were obtained as
indicated. When there was evidence of effusion, we ob-
tained synovial fluid for analysis by compensated po-
larized microscopy (seven members of the Argentinean
family and three members of the French family provided
aspirated synovial fluid for analysis). Both families dis-
played very similar phenotypes, with early age at onset
in the youngest affected members (3d decade of life) and
radiographic evidence of fibrocartilage and hyaline car-
tilage calcifications typical of CPPD deposition without
dysplasia or precocious osteoarthritis. The most com-
monly affected joints included knees and wrists; fibro-
cartilage tissues, including menisci, pubic symphysis, and
intervertebral disks, were also affected (Gaucher et al.
1977). In both families, laboratory studies of affected
individuals yielded no metabolic alterations: serum and
urinary calcium and magnesium and inorganic phos-
phates, alkaline phosphates, iron, iron-binding capacity,
and serum copper levels were normal. In the Argentinean
family, parathyroid-hormone levels were determined in
18 affected members and were normal. This study was
approved by the Institutional Review Board of Thomas
Jefferson University, Philadelphia, and by the Comite´
Consultatif de Protection des Personnes dans la Re-
cherche Biomedicale de Nancy.
DNA Microsatellite Marker Analyses
We extracted DNA from whole blood, with an au-
tomated nucleic acid extractor (ABI model 341, Gene-
pure), under conditions specified by the manufacturer.
Polymorphic dinucleotide-repeat markers from several
candidate loci, including a variety of extracellular-matrix
genes as well as the loci at 8q and 5p (Baldwin et al.
1995; Hughes et al. 1995), which have been reported
elsewhere to be linked to the chondrocalcinosis phe-
notype, were genotyped in all participating family mem-
bers. Markers (Weber et al. 1991; Gersh et al. 1994)
were analyzed following PCR amplification (Saiki et al.
1985) of 30 ng of genomic DNA in a 10–20-ml reaction
containing 5 pmol of each primer. Optimal magnesium
concentrations were determined for each primer pair. For
automated genotype analyses, fluorescently labeled PCR
products were visualized on an ABI model 373 sequencer
(Genepure) and analyzed with GENESCAN software
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Figure 1 A, Pedigree of Argentinean kindred. Member III-10 died during the course of the study, but two separate DNA samples were
obtained prior to her death. The subfamily denoted by “A.1” underwent linkage analysis; members of subfamily A.1 participating in genotype
analysis and used in linkage analysis included all living relatives except members IV-9 and IV-10. B, Pedigree of French kindred. Members
participating in genotype analysis and used for linkage analysis included all living relatives depicted.
(Applied Biosystems). For radioactive genotype analyses,
[33P]–end-labeled PCR products were resolved on a 6%
denaturing polyacrylamide gel and visualized by auto-
radiography (Maniatis et al. 1982).
Linkage Analyses
We performed two-point linkage analysis with the
FASTLINK 3.0P version of MLINK (Cottingham et al.
1993; Scha¨ffer et al. 1994). The disease was modeled as
an autosomal dominant trait with a reduced penetrance
of .9, since some asymptomatic individuals of the last
generation were still too young for the disease to be
detected either clinically or radiologically. Moreover,
since the phenotype being analyzed could, in a small
proportion of cases, also result from various factors
apart from the genetic component, we took into account
a phenocopy rate for affected individuals. Because
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Figure 2 Left, Radiograph of knee of member V-2 (aged 42 years) of the Argentinean kindred, showing calcific deposits in the knee
meniscus. Note that there is no evidence of osteoarthritis at this early stage of the disease; joint space, tibial plateau, and femoral condyle are
normal and uncompromised. Right, Lateral radiograph of knee of member IV-2 (proband, aged 77 years) showing late-stage disease progression.
Note severe osteoarthritis with narrowing of joint space and bone remodeling of patella, tibial plateau, and femoral condyle.
CPPDD mimics other rheumatic disorders (McCarty
1975), especially rheumatoid arthritis, we used annual
incidence values for rheumatoid arthritis in a general
population 118 years of age, which yielded phenocopy
rates of .0006 and .00022 for women and men, respec-
tively (Chan et al. 1993). The disease-allele frequency
was assumed to be .0001. We estimated marker-allele
frequencies with the FASTLINK 3.0P version of the
ILINK program, after breaking the only loop of the
Argentinean family (see fig. 1A, members III-3 and III-
4) to hasten the analyses. Since the familial form of
CPPDD is rare, we designated married-in individuals as
being unaffected; individuals for whom no clinical or
radiological evaluation was performed were designated
as unaffected in the same liability classes as the affected
members. A multipoint linkage analysis was also per-
formed when marker orders and intermarker distances
were recovered from various genome databases. We used
the VITESSE program (O’Connell and Weeks 1995) to
generate multipoint LOD scores.
Results
The detailed pedigrees of the two families analyzed in
this study are shown in figure 1A and B. The extended
history of the Argentinean family spanned seven gen-
erations. Confirmation of affected status was available
for a total of 162 members (143 living and 19 deceased)
from generations III–VI. Blood samples were obtained
from 77 members, from four generations, for genotype
analysis, as shown in figure 1A. All individuals who
donated blood underwent genotype analyses; however,
only members of subfamily A.1 (with the exception of
members IV-9 and IV-10, who declined to participate in
the study) underwent two-point linkage analysis (see be-
low). The French family could be traced through nine
generations; a detailed genealogy of the entire family,
through seven generations, has been published elsewhere
(Gaucher et al. 1977). Blood samples were available
from all living family members shown in figure 1B, and
all individuals underwent genotype and linkage analyses.
Clinical Features of Chondrocalcinosis in the Two
Families
Articular chondrocalcinosis was observed on joint ra-
diographs of 27 living members, and CPPD crystals were
identified by compensated polarized light microscopy of
the synovial fluids of seven patients from the Argenti-
nean kindred. For two of these patients, x-ray diffraction
and infrared spectroscopic analyses of calcified tissues
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Table 1
Two-Point LOD Scores for Argentinean and French Families
MARKER
AND
FAMILY
LOD SCORE AT v 
.00 .01 .05 .10 .20 .30 .40
D5S432 1.66 1.67 1.62 1.47 1.04 0.63 0.27
A.1 0.41 0.47 0.62 0.69 0.63 0.43 0.20
B 1.25 1.20 1.01 0.78 0.42 0.19 0.06
D5S817 6.02 8.10 8.26 7.67 5.73 3.42 1.28
A.1 3.95 3.96 3.92 3.72 3.01 2.04 0.91
B 2.07 4.14 4.34 3.95 2.72 1.39 0.37
D5S810 2.40 0.12 0.72 0.93 0.79 0.43 0.11
A.1 0.45 0.56 0.76 0.81 0.64 0.35 0.06
B 2.85 0.67 0.04 0.13 0.14 0.09 0.04
D5S2081 1.99 1.84 3.18 3.51 3.17 2.27 1.09
A.1 0.78 2.46 3.21 3.38 3.02 2.18 1.05
B 2.78 0.62 0.03 0.13 0.15 0.09 0.04
D5S1991 3.27 4.95 5.63 5.58 4.54 2.96 1.22
A.1 0.37 2.05 2.82 3.02 2.69 1.89 0.83
B 2.90 2.90 2.81 2.56 1.85 1.06 0.38
D5S1954 0.99 2.63 3.17 3.04 2.15 1.06 0.20
A.1 0.37 1.93 2.36 2.27 1.69 0.90 0.19
B 0.62 0.69 0.80 0.76 0.46 0.16 0.01
D5S1963 10.10 11.60 11.90 11.30 9.00 6.00 2.70
A.1 2.07 3.65 4.09 3.99 3.28 2.26 1.06
B 7.99 8.00 7.81 7.28 5.71 3.75 1.69
D5S416 1.67 3.41 4.27 4.39 3.70 2.50 1.14
A.1 0.65 2.33 3.10 3.28 2.94 2.12 1.02
B 1.01 1.08 1.17 1.11 0.75 0.38 0.12
D5S2114 0.50 4.20 5.80 6.00 5.00 3.20 1.30
A.1 6.67 2.89 0.78 0.11 0.63 0.51 0.19
B 7.17 7.06 6.56 5.88 4.37 2.73 1.14
D5S1997 2.79 7.96 8.24 7.74 5.93 3.71 1.59
A.1 3.51 1.75 2.47 2.63 2.33 1.65 0.79
B 6.29 6.20 5.77 5.11 3.59 2.06 0.79
D5S268 2.56 2.77 3.66 3.87 3.40 2.37 1.11
A.1 5.19 0.17 1.25 1.73 1.86 1.46 0.75
B 2.63 2.59 2.41 2.14 1.54 0.91 0.35
D5S486 3.23 1.92 2.34 2.29 1.85 1.25 0.58
A.1 3.23 1.93 2.35 2.29 1.85 1.26 0.59
B ND ND ND ND ND ND ND
NOTE.—Values in lines beginning with marker names are combined
LOD scores for family A.1 and family B. The highest LOD scores
obtained are underlined. ND  not done.
confirmed the presence of CPPD crystals. Clinical pat-
terns in affected members comprised pseudogout alone
(19%), pseudogout plus osteoarthritis (44%), pseudo-
osteoarthritis alone (22%), and pseudo–rheumatoid ar-
thritis (15%). One member demonstrated radiographic
evidence of CPPDD but was clinically asymptomatic.
The mean age at onset was 29 years (range 17–60 years).
Among affected members, 93% had radiographic evi-
dence of chondrocalcinosis in the knees, 67% had in-
volvement of the pubis symphysis, and 59% and 52%
showed involvement of the wrists and hips, respectively.
Eight affected members had severe, destructive arthrop-
athy of the hips, knees, and shoulders; six of them had
required total hip replacement (bilateral for two of the
six members), and knee replacement had been performed
on two members. The lumbar spine was also affected in
some members.
Clinical as well as biochemical profiles of the French
CPPDD family have been extensively characterized. De-
tails of the clinical phenotype were described by Gaucher
et al. (1977); in brief, affected family members had a
diffuse form of the disease. CPPD deposits were observed
in cartilage linings and fibrocartilages, including menisci,
glenoidal and cotyloid labra, pubis symphysis, and in-
tervertebral disks. Calcifications were also detected in
joint capsules and ligaments. The crystals obtained from
joints of three affected members were identified, by x-
ray diffraction analysis, as CPPD in the triclinic crys-
talline form (Lust et al. 1981b). A study of lymphoblasts
and fibroblasts from members of the family demon-
strated a mean concentration of intracellular pyrophos-
phate that was two times higher than that observed in
cells from unaffected family members and from other,
unrelated controls (Lust et al. 1981a, 1981b). Finally,
no association with or linkage to any human leukocyte
antigen was observed in this kindred (Gaucher et al.
1977).
Figure 2 shows knee radiographs of members V-2 (left
panel) and IV-2 (right panel) of the Argentinean kindred.
Member V-2 was a 42-year-old woman who developed
CPPDD in her mid 30s. Her mother (member IV-2), the
proband, underwent hip replacement at the age of 50
years; her age at onset was 30 years.
Two-Point Linkage Analyses
The first family from whom samples were collected
and analyzed was the Argentinean kindred. Because of
reported locus heterogeneity for chondrocalcinosis, we
tested a number of candidate loci, including several car-
tilage extracellular-matrix genes and the locus on chro-
mosome 8q (Baldwin et al. 1995), through two-point
linkage analysis by means of an affecteds-only dominant
model that considered only affected individuals to be in
a liability class with complete penetrance. The family
showed no linkage to all the loci considered, with the
exception of a locus on the short arm of chromosome
5, where there was evidence for linkage but at a recom-
bination fraction (v) 10 (data not shown). On the basis
of haplotype analysis, two individuals (member III-10
and her daughter, member IV-18) who were scored as
affected did not exhibit the disease haplotype as defined
for 25 other affected members in the kindred. Unfor-
tunately, the clinical profiles of these two members were
entirely consistent with those described for other affected
members of the family, including a clinical presentation
of pseudogout and chondrocalcinosis of the wrists, pubis
symphysis, and knees; thus, it was impossible to distin-
guish these individuals from other affected members, on
the basis of their phenotype. Since CPPDD is a condition
Figure 3 Recombination analysis of genotypes for relevant nuclear families in the Argentinean and French kindreds. Marker order is
indicated to the left of the first individual in each generation. Alleles transmitted by the spouses of members of the top generation for each
family are shown as unblackened boxes; alleles transmitted by spouses of subsequent generations in the Argentinean family are shown as black
lines. Pedigree numbers correspond to the pedigree positions shown in fig. 1A and B. The haplotype linked to the disease gene is shown in
black. A, Recombinants in the Argentinean kindred. B, Recombinants in the French kindred. Member VII-20 (aged 31 years) was still unaffected
at the time of this study.
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Figure 4 Multipoint linkage analysis for the Argentinean kin-
dred. Multipoint plots for both the entire Argentinean kindred (family
A) and subfamily A.1 of the Argentinean kindred are depicted. Inter-
marker distances were obtained from public databases. We used
VITESSE to generate the multipoint LOD scores (location scores ex-
pressed as LOD scores) by means of a six-point window (five markers
and the disease locus) across an interval defined by the indicated
markers.
that may result from a variety of metabolic, traumatic,
and genetic abnormalities (Moskowitz 1993), we con-
sidered these members to be potential phenocopies. In
an attempt to define the nature of the phenocopy in these
members, we first excluded several metabolic disorders
or trauma as the cause of the observed phenotype. Lack-
ing any resolution with this strategy, we next analyzed
the family of the spouse of member II-3, from whom
the haplotype of these two anomalous members was
inherited, to investigate whether we could be dealing
with a family segregating two different disease haplo-
types. Interestingly, among 28 members of this extended
family who were examined, 6 were affected with chon-
drocalcinosis or pyrophosphate arthropathy (a radio-
logically distinct and phenotypically severe arthropathy
that is often associated with advanced-stage CPPDD; see
Dieppe et al. 1982). However, linkage analysis of this
extended family, under the assumption of an autosomal
dominant mode of inheritance, excluded linkage to the
5p locus (data not shown). The above-mentioned ob-
servations, however, led us to reanalyze the Argentinean
family by eliminating the branch of the kindred that
produced the anomalous members. Therefore, the
branch of the Argentinean kindred that underwent two-
point linkage analysis, labeled “A.1” in figure 1A, in-
cluded genotype data from all living members depicted,
with the exception of members IV-9 and IV-10 (table 1,
family A.1). Confidence in the chromosome 5p locus was
supported by linkage analysis of an unrelated French
family displaying the same chondrocalcinosis pheno-
type. The two-point LOD scores for the French family
(family B) are also shown in table 1; we performed link-
age analysis by means of genotype data provided by all
living relatives shown in figure 1B. Table 1 also includes
the combined LOD score for both families (family A.1
and family B) and demonstrates a maximum two-point
LOD score of 11.90 at the marker D5S1963 ( ).v  .05
We performed the tabulated analyses by means of the
model specifications described in Subjects, Material, and
Methods. An affecteds-only analysis with reduced pen-
etrance (.9) was also performed for both families, with
similar results (not shown).
Recombination Analyses and Multipoint Linkage
Analyses
Recombination events in the haplotype analysis of the
pertinent nuclear family of the Argentinean kindred are
shown in figure 3A. Three affected members showed
recombination at the CPPDD locus; the disease haplo-
type observed in members IV-1 and V-1 places the
CPPDD disease gene telomeric to marker D5S2114, and
recombination in the disease haplotype of member V-7
indicates that the CPPDD gene is just centromeric to the
D5S416 marker. In the French kindred, only one indi-
vidual with recombination in the disease haplotype has
been observed; as seen in figure 3B, member VII-19 car-
ries the disease locus just centromeric to the marker
D5S1991. Since the recombination analyses of the Ar-
gentinean kindred were the most informative with re-
spect to specifying the disease interval, multipoint link-
age analysis was undertaken to further specify the
CPPDD locus. Results of the multipoint analysis of the
entire Argentinean family (family A), as well as of sub-
family A.1, show a peak between markers D5S416 and
D5S2114, in a 1-cM interval, as can be seen in figure
4. An ideogram of the short arm of chromosome 5,
depicting the most likely location of the CPPDD locus
in the Argentinean and French kindreds, is shown in
figure 5.
Discussion
This report identifies two more unrelated CPPDD
families with phenotypes that show linkage to chro-
mosome 5p. Analysis of recombinations in three affected
members of the Argentinean kindred narrows the region
of search for the candidate gene to the interval between
the markers D5S416 and D5S2114, a distance interval
of !1 cM. There are no other microsatellite markers in
this interval (C. J. Williams and J. Overhauser, unpub-
lished data). No candidate genes have been mapped to
this interval; however, one expressed sequence tag (EST)
has been identified (dbEST accession no. 182111;
GenBank accession no. R11532) and may be considered
a candidate for the CPPDD gene.
The clinical pattern of the disease in the two families
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Figure 5 Ideogram of the short arm of chromosome 5, showing the CPPDD interval for the Argentinean and French families. Sex-averaged
distances between markers are shown in centromeres.
reported here is somewhat different from that reported
for other CPPDD families for which linkage analysis has
been performed. In a large New England family in which
linkage to chromosome 8q was noted, it was unclear
whether CPPD deposition that progressed to degenera-
tive joint disease was the primary event causing the dis-
ease or whether the degenerative changes in cartilage
resulting from osteoarthritis enhanced the deposition of
calcium-containing crystals (Baldwin et al. 1995). In a
British kindred with chondrocalcinosis linked to chro-
mosome 5p, the most likely candidate interval maps just
distal to that specified by our families. Once again, how-
ever, the disease phenotype in this family is different
from that displayed by our two families in that all af-
fected individuals in the British kindred also experienced
recurrent childhood seizures (Hughes et al. 1995). No
such seizures were reported for any members of the two
families that we studied. There still remain several fam-
ilies in the clinical literature whose phenotypes are very
similar to those observed in the French and Argentinean
families that we describe. In particular, a large kindred
from Tunisia has been studied in which the clinical pat-
tern of disease somewhat resembles that found in our
families (Hamza et al. 1992). The phenotype in this fam-
ily is also inherited as an autosomal dominant trait with
somewhat reduced penetrance; however, no linkage
analysis has yet been undertaken. The study of this fam-
ily and other families with evidence of crystal deposition
that precedes degenerative joint changes would make
valuable additions to the study of the genetics of familial
CPPDD.
The frequency of CPPDD in the general population
is estimated to be ∼10% (Felson et al. 1989; Sanmarti
et al. 1993); however, this figure includes all types of
chondrocalcinosis, including the type that occurs sub-
sequent to late-stage osteoarthritis. The frequency of
CPPDD in this context may be 150% among patients
aged 180 years. Although the candidate gene that causes
familial CPPDD as described here may not be wholly
responsible for calcium deposition in the sporadic and
more common forms of CPPDD, a knowledge of the
biochemistry of crystal deposition in heritable CPPDD
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may lead to a better understanding of mechanisms of
calcium deposition in advanced osteoarthritis and other
metabolic disorders.
Notes added in proof: Subsequent to the submission
of this manuscript, additional members of the French
family underwent genotype analysis. These members in-
cluded one affected sibling of members VII-1 and VII-2
of family B. A recombination between the markers
D5S416 and D5S2114 was revealed in this new member,
such that his disease haplotype encompassed the region
telomeric to marker D5S2114. Furthermore, the EST
database has been updated and additional ESTs have
been mapped to the candidate interval described in this
report.
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